The main prognostic factors used at our institution to discuss whether a genomic test should be performed were: nodal involvement (0 to 3 positive nodes), three proliferative markers (Ki67, tumor grade and mitotic index), and tumor size. The gene discussed is MKI67; the disease is neoplasm.